Impact of artificial intelligence based scoring of hormone expression in breast cancer on treatment decision making.
Not Applicable
- Conditions
- Health Condition 1: C509- Malignant neoplasm of breast of unspecified site
- Registration Number
- CTRI/2021/03/031926
- Lead Sponsor
- Applied Materials India PVT LTD
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Female patients, post-surgery with diagnosed breast carcinoma subjected to immunohistochemical analysis of hormone receptors(ER, PR, Her2-neu and Ki67) on the breast specimen.
Exclusion Criteria
Cases were consent could not be obtained
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method tility and effectiveness of computer assisted artificial intelligence (AI) based analysis to objectively quantify the biomarker expression in breast cancer.Timepoint: 4 months
- Secondary Outcome Measures
Name Time Method Impact of AI based scoring in deciding therapy modulation in patient diagnosed with breast cancer.Timepoint: 4 months